Scilex Holding (SCLX) Change in Cash (2020 - 2026)

Scilex Holding (SCLX) posted quarterly Change in Cash of -$1.6 million for Q1 2026, down 163.45% year-over-year from $2.5 million in Q1 2025, and down 139.34% on a QoQ basis from $4.1 million in Q4 2025.

Scilex Holding (SCLX) Change in Cash (2020 - 2026) Analysis & Trends

Scilex Holding (SCLX) has reported Change in Cash for 7 consecutive years, with -$1.6 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Change in Cash fell 163.45% year-over-year to -$1.6 million; the TTM figure through Mar 2026 stood at -$2.4 million (down 180.93% YoY), while the FY2025 annual figure was $1.7 million, up 215.51% from the prior year.
  • Change in Cash came in at -$1.6 million for Q1 2026 at Scilex Holding, down from $4.1 million in the prior quarter.
  • The five-year high for Change in Cash was $30.1 million in Q2 2023, with the low at -$33.1 million in Q3 2023.
  • Average Change in Cash over 5 years is -$58058.8, with a median of -$1.5 million recorded in 2024.
  • The largest YoY upside for Change in Cash was 10177.14% in 2022 against a maximum downside of 11874.91% in 2022.
  • Year by year, Change in Cash stood at -$299000.0 in 2022, then surged by 1019.4% to $2.7 million in 2023, then tumbled by 276.21% to -$4.8 million in 2024, then jumped by 184.17% to $4.1 million in 2025, then slumped by 139.34% to -$1.6 million in 2026.
  • According to Business Quant data, Change in Cash over the past three periods registered -$1.6 million, $4.1 million, and -$3.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -1.99 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 1.98 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 4.16 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 5.70 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -9.29 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 2.91 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 65.00 Mn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 563.00 Mn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Scilex Holding 54.30 Mn -95.62 Mn 4.15 Mn -1.60 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.60 Mn
Dec 31, 2025 4.08 Mn
Sep 30, 2025 -3.22 Mn
Jun 30, 2025 -1.70 Mn
Mar 31, 2025 2.53 Mn
Dec 31, 2024 -4.84 Mn
Sep 30, 2024 -1.55 Mn
Jun 30, 2024 6.89 Mn
Mar 31, 2024 -1.96 Mn
Dec 31, 2023 2.75 Mn
Sep 30, 2023 -33.15 Mn
Jun 30, 2023 30.06 Mn
Mar 31, 2023 2.89 Mn
Dec 31, 2022 -299,000.00
Sep 30, 2022 -4.34 Mn
Jun 30, 2022 -26.74 Mn
Mar 31, 2022 29.23 Mn
Dec 31, 2021 -586,131.00
Sep 30, 2021 -426,387.00
Jun 30, 2021 227,110.00